Shivee Gilja, MD
MD: Icahn School of Medicine at Mount Sinai
Hometown: Manhasset, NY
Personal Statement: I am so excited to have matched the research track at WashU and join a program with such exceptional clinical training and endless research opportunities! I feel fortunate to join a legacy of amazing otolaryngologists who have trained at WashU, including some of my own mentors from medical school.
Education
Undergraduate: BS, Cellular & Molecular Biology, Visual Arts, Duke University, 2017
Medical School: Icahn School of Medicine at Mount Sinai, 2024
Honors/Awards
- Graduation with Distinction in Research, Icahn School of Medicine at Mount Sinai, 2024
- Medical Student Travel Grant, American Association of Otolaryngology-Head and Neck Surgery Annual Meeting, 2023
- 2nd Place Moderated Poster Competition, American Head and Neck Society 11th International Conference, 2023
- 3rd Place Moderated Poster Competition, American Head and Neck Society 11th International Conference, 2023
- Overall 1st Place Winner and 1st Place in Category, Society for Vascular Surgery, Karmody Poster Competition, 2021
- Karen Zier Summer Research Award, Icahn School of Medicine at Mount Sinai, 2020
- B.S. awarded cum laude, Duke University, 2017
- Graduation with High Distinction, Duke University, 2017
- Poster Prize, Consortium for Canine Comparative Oncology Symposium, 2017
- Schiff Research Fellow Scholarship, Duke University, 2014
Publications
- Vasan V, Gilja S, Kapustin D, Yun J, Roof SA, Chai RL, Khan MN, Rubin SJ. The impact of distance to facility on treatment modality, short-term outcomes, and survival of patients with HPV-positive oropharyngeal squamous cell carcinoma. Am J Otolaryngol. 2024 Jul-Aug;45(4):104356. doi: 10.1016/j.amjoto.2024.104356. PMID: 38703611.
- Gilja S, Vasan V, Kumar A, Roof SA, Genden EM, Kirke DN. Treatment discordance in the utilization of neck dissection for stage I-II supraglottic tumors. Head Neck. 2024 Jul;46(7):1589-1600. doi: 10.1002/hed.27736. PMID: 38482913.
- Barlow J, Gilja S, Ferrandino RM, Berger MH, Posner MR, Bakst RL, Khan MN, Teng MS, Genden EM, Chai RL, Roof SA. Evaluating human papillomavirus testing, prevalence, and association with prognosis in head and neck squamous cell carcinoma by subsite: A national cancer database study. Am J Otolaryngol. 2024 May-Jun;45(3):104243. doi: 10.1016/j.amjoto.2024.104243. PMID: 38442460.
- Kumar A, Kumar S, Gilja S, Mathey-Andrews CA, Potter AL, Jeffrey Yang CF, Auchincloss HG. Surgery for M1A Non-Small-Cell Lung Cancer With Additional Pulmonary Nodules in a Contralateral Lobe. J Surg Res. 2024 Mar;295:102-111. doi: 10.1016/j.jss.2023.10.025. PMID: 38006777.
- Gilja S, Kumar A, Kapustin D, Su V, Rubin SJ, Chai R, Roof SA, Khan MN. The Impact of Hospital Safety-Net Burden Status on Patients with HPV-Positive Oropharyngeal Cancer. Laryngoscope. 2024 Apr;134(4):1733-1740. doi: 10.1002/lary.31131. PMID: 37933810.
- Kumar A,Gandhi K, Gilja S, Potter AL, Mathey-Andrews C, Auchincloss HG, Yang CJ. Multimodal Therapy for T4N2 Non-small-cell Lung Cancer with Additional Ipsilateral Pulmonary Nodules. Annals of Thoracic Surgery Short Reports 2023;4(1):566-569. doi: 10.1016/j.atssr.2023.06.010.
- Gilja S, Barlow J, Kumar A, Berger MH, Khan MN, Kirke DN, Roof, SA. Evaluating Depth of Invasion Across Oral Cavity Subsites as Part of the AJCC 8th Edition T Staging Criteria for Oral Cavity Squamous Cell Carcinoma. Head and Neck. 2023;45(11):2780-2788. doi: 10.1002/hed.27497. PMID: 37698539.
- Gilja S, Kumar A, Vasan V, Roof SA, Genden EM, Kirke DN. The impact of undergoing surgical margin evaluation during endoscopic surgery for early-stage laryngeal squamous cell carcinoma. Head and Neck. 2023;45(10):2680-2689. PMID: 37642204.
- DiRisio AC, Feng R, Shuman WH, Platt S, Price G, Dullea JT, Gilja S, D’Andrea MR, Delman BN, Bederson JB, Shrivastava RK. The Knosp Criteria Revisited: 3-Dimensional Volumetric Analysis as a Predictive Tool for Extent of Resection in Complex Endoscopic Pituitary Surgery. Neurosurgery. 2023;92(1):179-185. PMID: 36170168.
- Rutland JW, Dullea JT, Oermann EK, Feng R, Villavisanis DF, Gilja S, Shuman W, Lander T, Govindaraj S, Iloreta AMC Jr, Chelnis J, Post K, Bederson JB, Shrivastava RK. Post-operative vision loss: analysis of 587 patients undergoing endoscopic surgery for pituitary macroadenoma. British Journal of Neurosurgery 2022;9:1-7. PMID: 35264032.
- Gilja S [co-first author], Thomas AT, Sikka N, Onuh O, Kellner R, Schussler L, Sun M, Hurtado AM. Peer-to-peer COVID-19 medical curriculum development during the pandemic. Medical Education 2021;55(11):1302-1303. PMID: 34486153.
- Kumar A, Kumar S, Gilja S, Potter A, Jeffrey Yang CF. Encouraging Guideline-Concordant Treatment for T3 NSCLC. Journal of Thoracic Oncology 2021;16(12):e98-e99. PMID: 34809807.
- Kumar A, Kumar S, Gilja S, Potter A, Raman V, Muniappan A, Liou D, Yang CJ. Reconsidering the American Joint Committee on Cancer 8th Edition TNM Staging Manual Classifications for T2b/T3 Non-small-cell Lung Cancer. Journal of Thoracic Oncology 2021;16(10):1672-1683. PMID: 34242788
- Jolly MK, Ware KE, Xu S, Gilja S, [and 19 others] E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms. Molecular Cancer Research 2019;17(6):1391-1402. PMID: 30862685.
- Ware KE, Gilja S, Xu S, Shetler S, Jolly MK, Wang X, Bartholf Dewitt S, Hish AJ, Jordan S, Eward W, Levine H, Armstrong AJ, Somarelli JA. Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells. Journal of Visualized Experiments 2017;7(122):55520. PMID: 28448023.
- Jolly MK, Ware KE, Gilja S, Somarelli JA, Levine H. EMT and MET: necessary or permissive for metastasis? Molecular Oncology 2017;11(7):755-769. PMID: 28548345.
- Somarelli JA, Shetler S, Jolly MK, Wang X, Bartholf Dewitt S, Hish AJ, Gilja S, Eward WC, Ware KE, Levine H, Armstrong AJ, Garcia-Blanco MA. Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. Molecular and Cellular Biology 2016;36(19):2503-13. PMID: 27402864. *Spotlight and Cover Article